Recent studies indicate that probiotics can stimulate intestinal immunity and tighten the
junctions of epithelial cells. By these ways, probiotics can reduce bacterial translocation;
hence, they can ameliorate systemic inflammatory status. Because cirrhotic patients with
portal hypertension often suffer from infections from intestinal flora, the investigators
speculate that probiotics will be beneficial to those patients.